Search
Spotlight
ASH 2020 News
Global Oncology News
Neoadjuvant HER2+
CAR-T Cell Therapy Learning Module
Colorectal Cancer
Interactive Tools
Targeted Therapy in Blastic Plasmacytoid Dendritic Cell Neoplasm
Utilizing Tumor Metabolism in Solid Malignancies
ASH 2020 News
Global Oncology News
Neoadjuvant HER2+
CAR-T Cell Therapy Learning Module
Colorectal Cancer
Interactive Tools
Targeted Therapy in Blastic Plasmacytoid Dendritic Cell Neoplasm
Utilizing Tumor Metabolism in Solid Malignancies
Specialty
View More
Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
News
Media
Insights
Medical World News
News Network
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
News Network
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
OncLive Events Scientific Interchange Workshop Series
PER Events
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
OncLive Events Scientific Interchange Workshop Series
PER Events
State of the Science Summit / IPC
Webinars
Publications
Resources
CME/CE
Community
Interactive Tools
Learning Modules
Partners
Pipeline Report
Sponsored
CME/CE
Community
Interactive Tools
Learning Modules
Partners
Pipeline Report
Sponsored
Subscribe
eNewsletter
eNewsletter
Search
Spotlight
ASH 2020 News
Global Oncology News
Neoadjuvant HER2+
CAR-T Cell Therapy Learning Module
Colorectal Cancer
Interactive Tools
Targeted Therapy in Blastic Plasmacytoid Dendritic Cell Neoplasm
Utilizing Tumor Metabolism in Solid Malignancies
Specialty
See All >
Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
OncLive Insights
®
All Topics
Biosimilars
Brain Cancer
Breast Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Insights
Lung Cancer
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Multiple Myeloma
Myeloproliferative Neoplasms
Neoadjuvant HER2+
Non-Hodgkin Lymphoma
Oncology Nursing News
Ovarian Cancer
Pediatric Hematology Oncology
Precision Medicine in Oncology®
Prostate Cancer
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Urology
Apply
Treatment Approach in Advanced Melanoma
EP. 1:
Introduction to Melanoma
EP. 1:
Introduction to Melanoma
EP. 2:
Testing and BRAF Mutations in Melanoma
EP. 2:
Testing and BRAF Mutations in Melanoma
EP. 3:
A Look at the KEYNOTE-054 and COMBI-AD Data
EP. 3:
A Look at the KEYNOTE-054 and COMBI-AD Data
EP. 4:
Treatment Goals and Patient Decisions in Melanoma
EP. 4:
Treatment Goals and Patient Decisions in Melanoma
EP. 5:
The Role of COVID-19 in Adjuvant Treatment Decisions in Melanoma
EP. 5:
The Role of COVID-19 in Adjuvant Treatment Decisions in Melanoma
EP. 6:
Molecular Testing in Metastatic Melanoma
EP. 6:
Molecular Testing in Metastatic Melanoma
BCMA as a Target in Heavily Pre-Treated RRMM
EP. 1:
Treatment Approach for R/R Multiple Myeloma
EP. 1:
Treatment Approach for R/R Multiple Myeloma
EP. 2:
The Rationale for Targeting BCMA in Multiple Myeloma
EP. 2:
The Rationale for Targeting BCMA in Multiple Myeloma
EP. 3:
DREAMM-2 Trial Efficacy Data and Recent FDA Approval
EP. 3:
DREAMM-2 Trial Efficacy Data and Recent FDA Approval
EP. 4:
DREAMM-2 Trial Regimen Safety Profile
EP. 4:
DREAMM-2 Trial Regimen Safety Profile
EP. 5:
Management of Ocular Events From DREAMM-2 Regimen
EP. 5:
Management of Ocular Events From DREAMM-2 Regimen
EP. 6:
DREAMM-2 Trial Regimen: Safety Updates and Dose Delay
EP. 6:
DREAMM-2 Trial Regimen: Safety Updates and Dose Delay
Modern Perspectives in Advanced Melanoma
EP. 1:
The Optimal Approach to Treating Advanced Melanoma
EP. 1:
The Optimal Approach to Treating Advanced Melanoma
EP. 2:
Impact of MSLT-II Data on Completion Lymph Node Dissection
EP. 2:
Impact of MSLT-II Data on Completion Lymph Node Dissection
EP. 3:
Neoadjuvant Melanoma Therapy: Patient Selection
EP. 3:
Neoadjuvant Melanoma Therapy: Patient Selection
EP. 4:
Importance of Molecular Testing in Stage III Melanoma
EP. 4:
Importance of Molecular Testing in Stage III Melanoma
EP. 5:
Adjuvant Clinical Trial Data Impact on Treatment Selection
EP. 5:
Adjuvant Clinical Trial Data Impact on Treatment Selection
EP. 6:
Adjuvant Therapy in Stage IIIB/IIIC/IIID Melanoma
EP. 6:
Adjuvant Therapy in Stage IIIB/IIIC/IIID Melanoma
EP. 7:
Balancing Safety and Efficacy in Adjuvant Therapy
EP. 7:
Balancing Safety and Efficacy in Adjuvant Therapy
EP. 8:
Short-Term COVID-19 NCCN Recommendations
EP. 8:
Short-Term COVID-19 NCCN Recommendations
EP. 9:
BRAF-Wild Type vs Mutated Unresectable Melanoma
EP. 9:
BRAF-Wild Type vs Mutated Unresectable Melanoma
EP. 10:
Metastatic Melanoma Long-Term Survival Data
EP. 10:
Metastatic Melanoma Long-Term Survival Data
EP. 11:
Long-Term Survival Data in Adjuvant Therapy
EP. 11:
Long-Term Survival Data in Adjuvant Therapy
EP. 12:
Emerging Treatments for Advanced Melanoma
EP. 12:
Emerging Treatments for Advanced Melanoma
Emerging Strategies for Renal Cell Carcinoma
EP. 1:
The Biology of RCC and Improved Treatment Outcomes
EP. 1:
The Biology of RCC and Improved Treatment Outcomes
EP. 2:
Tumor Biology in Favorable to Poor-Risk RCC
EP. 2:
Tumor Biology in Favorable to Poor-Risk RCC
EP. 3:
Improved Outcomes With Novel and Combination Therapies
EP. 3:
Improved Outcomes With Novel and Combination Therapies
EP. 4:
Risk Assessment and Diagnostic Work-up
EP. 4:
Risk Assessment and Diagnostic Work-up
EP. 5:
Newly Diagnosed RCC: KEYNOTE-426 and CheckMate-214
EP. 5:
Newly Diagnosed RCC: KEYNOTE-426 and CheckMate-214
EP. 6:
The Role of VEGF TKI Monotherapy
EP. 6:
The Role of VEGF TKI Monotherapy
EP. 7:
Impact of the Phase 3 CheckMate 9ER Trial on Practice
EP. 7:
Impact of the Phase 3 CheckMate 9ER Trial on Practice
EP. 8:
The Role of Combination Treatment in RCC
EP. 8:
The Role of Combination Treatment in RCC
EP. 9:
The Future Treatment Landscape of RCC
EP. 9:
The Future Treatment Landscape of RCC
EP. 10:
Emerging Therapies for Relapsed/Refractory MRCC
EP. 10:
Emerging Therapies for Relapsed/Refractory MRCC
Treating Advanced RAI-Refractory DTC: A Two-Way Street: Medical Oncology and Endocrinology
EP. 1:
Differentiated Thyroid Cancer: Increasing Incidence
EP. 1:
Differentiated Thyroid Cancer: Increasing Incidence
EP. 2:
DTC: Histological Subtypes and Tumor Differentiation
EP. 2:
DTC: Histological Subtypes and Tumor Differentiation
EP. 3:
Role of Radioiodine Treatment in DTC
EP. 3:
Role of Radioiodine Treatment in DTC
EP. 4:
Thyrotropin Suppression as DTC Treatment Option
EP. 4:
Thyrotropin Suppression as DTC Treatment Option
EP. 5:
Clinical Scenarios to Consider for RAI-Refractory DTC
EP. 5:
Clinical Scenarios to Consider for RAI-Refractory DTC
EP. 6:
Discussing Iodine-Refractory DTC With Patients
EP. 6:
Discussing Iodine-Refractory DTC With Patients
EP. 7:
Management of DTC in Clinical Practice
EP. 7:
Management of DTC in Clinical Practice
EP. 8:
Roles and Communication in Treatment in DTC
EP. 8:
Roles and Communication in Treatment in DTC
EP. 9:
Understanding Sequencing and What to Look for in DTC
EP. 9:
Understanding Sequencing and What to Look for in DTC
EP. 10:
Approaching Treatment of Low-Volume DTC
EP. 10:
Approaching Treatment of Low-Volume DTC
EP. 11:
Multidisciplinary Management for the Treatment of DTC
EP. 11:
Multidisciplinary Management for the Treatment of DTC
EP. 12:
RAI-Refractory DTC Trials: Phase 3 DECISION and SELECT
EP. 12:
RAI-Refractory DTC Trials: Phase 3 DECISION and SELECT
EP. 13:
Sorafenib and Lenvatinib Side Effect Profile and Dosing
EP. 13:
Sorafenib and Lenvatinib Side Effect Profile and Dosing
Treatment Options in Metastatic Renal Cell Carcinoma
EP. 1:
Renal Cell Carcinoma and Novel Therapies
EP. 1:
Renal Cell Carcinoma and Novel Therapies
EP. 2:
Supportive Care and Systemic Therapy for RCC
EP. 2:
Supportive Care and Systemic Therapy for RCC
EP. 3:
Supportive Care and Systemic Therapy for RCC
EP. 3:
Supportive Care and Systemic Therapy for RCC
EP. 4:
Newly Diagnosed RCC: Treatment Planning
EP. 4:
Newly Diagnosed RCC: Treatment Planning
EP. 5:
Risk Stratification in Renal Cell Carcinoma
EP. 5:
Risk Stratification in Renal Cell Carcinoma
EP. 6:
mRCC Risk Assessment and Treatment Options
EP. 6:
mRCC Risk Assessment and Treatment Options
EP. 7:
Treatment Planning and Risk Assessment in mRCC
EP. 7:
Treatment Planning and Risk Assessment in mRCC
EP. 8:
Supportive Care for mRCC: Current Practices
EP. 8:
Supportive Care for mRCC: Current Practices
EP. 9:
Selecting Frontline Therapy for mRCC
EP. 9:
Selecting Frontline Therapy for mRCC
EP. 10:
mRCC: Moving to Second-Line Therapy
EP. 10:
mRCC: Moving to Second-Line Therapy
EP. 11:
Second-Line Treatment Approaches for mRCC
EP. 11:
Second-Line Treatment Approaches for mRCC
EP. 12:
Lenvatinib for mRCC
EP. 12:
Lenvatinib for mRCC
Load More
x